相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system
S Mazzetti et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2015)
A Translational Murine Model of Sub-Lethal Intoxication with Shiga Toxin 2 Reveals Novel Ultrastructural Findings in the Brain Striatum
Carla Tironi-Farinati et al.
PLOS ONE (2013)
Decreased VEGF expression and microvascular density, but increased HIF-1 and 2α accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain
Girriso F. Benderro et al.
BRAIN RESEARCH (2012)
Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults
Karin Weissenborn et al.
NEUROLOGY (2012)
Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6
Carol L. Murray et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα
Bin Xing et al.
MOLECULAR NEURODEGENERATION (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities
Carla Tironi-Farinati et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Masaki Ueno
CURRENT NEUROPHARMACOLOGY (2009)
Shiga Toxin 2 Targets the Murine Renal Collecting Duct Epithelium
Mitchell A. Psotka et al.
INFECTION AND IMMUNITY (2009)
Pulmonary Inflammation Triggered by Ricin Toxin Requires Macrophages and IL-1 Signaling
Meghan L. Lindauer et al.
JOURNAL OF IMMUNOLOGY (2009)
Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains
Javier Boccoli et al.
BRAIN RESEARCH (2008)
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons
Fumiko Obata et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The role of the complement cascade in endotoxin-induced septic encephalopathy
Alexander Jacob et al.
LABORATORY INVESTIGATION (2007)
Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: An ultrastructural study
Jorge Goldstein et al.
BRAIN RESEARCH (2007)
A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease
Tiffany R. Keepers et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific
Carola Foerster et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Predictors of fatality in postdiarrheal hemolytic uremic syndrome
RS Oakes et al.
PEDIATRICS (2006)
Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats
CL Robertson et al.
EXPERIMENTAL NEUROLOGY (2006)
The endothelial glycocalyx: a potential barrier between health and vascular disease
M Nieuwdorp et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis
G Candiano et al.
ELECTROPHORESIS (2004)
Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures
AA Khaibullina et al.
DEVELOPMENTAL BRAIN RESEARCH (2004)
Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes
KRK Winter et al.
INFECTION AND IMMUNITY (2004)
Astrogliosis in the adult and developing CNS: Is there a role for proinflammatory cytokines?
AR Little et al.
NEUROTOXICOLOGY (2001)
The central Scotland Escherichia coli O157:H7 outbreak:: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients
S Dundas et al.
CLINICAL INFECTIOUS DISEASES (2001)
Response to shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome
RL Siegler et al.
AMERICAN JOURNAL OF NEPHROLOGY (2001)
Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome
F Proulx et al.
PEDIATRIC RESEARCH (2001)
Acute neurology and neurophysiology of haemolytic-uraemic syndrome
KJ Eriksson et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2
J Sugatani et al.
THROMBOSIS RESEARCH (2000)
Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice
XP Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response
PT Kimmitt et al.
EMERGING INFECTIOUS DISEASES (2000)
Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157 : H7
E Kita et al.
INFECTION AND IMMUNITY (2000)
Glucocorticoids reduce interleukin-1 beta concentration and result in neuroprotective effects in raf heatstroke
CC Liu et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)